These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 814132)

  • 1. Recurrent hyperthyroidism in an acromegalic patient previously treated with proton beam irradiation: Graves' disease as probable etiology based on follow-up observations.
    Sandler R
    J Clin Endocrinol Metab; 1976 Jan; 42(1):163-8. PubMed ID: 814132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
    Kasagi K; Tamai H; Morita T; Hidaka A; Hatabu H; Misaki T; Iida Y; Ishihara T; Ikekubo K; Kuma K
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly and toxic goiter. Cure of the hyperthyroidism and acromegaly by proton-beam partial hypophysectomy.
    Hamilton CR; Maloof F
    J Clin Endocrinol Metab; 1972 Nov; 35(5):659-64. PubMed ID: 4677773
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine.
    Shenkman L; Mitsuma T; Hollander CS
    J Clin Invest; 1973 Jan; 52(1):205-9. PubMed ID: 4629908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
    Clifton-Bligh P; Silverstein GE; Burke G
    J Clin Endocrinol Metab; 1974 Apr; 38(4):531-8. PubMed ID: 4206830
    [No Abstract]   [Full Text] [Related]  

  • 9. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory dynamics of growth hormone in an acromegalic patient associated with Graves' disease.
    Shimatsu A; Murabe H; Sasaki S; Hattori N; Tanoh T; Imura H
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1059-63. PubMed ID: 2119390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient lack of thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in treated hyperthyroid patients with normal or low serum thyroxine (T4) and triiodothyronine (T3).
    Sanchez-Franco F; García MD; Cacicedo L; Martin-Zurro A; Escobar del Ray F; Morreale de Escobar G
    J Clin Endocrinol Metab; 1974 Jun; 38(6):1098-102. PubMed ID: 4208806
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
    Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181
    [No Abstract]   [Full Text] [Related]  

  • 15. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthyroidism due to excess thyrotropin secretion: follow-up studies.
    Mihailovic V; Feller MS; Kourides IA; Utiger RD
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1135-8. PubMed ID: 7372792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of acromegaly associated with Graves' disease. A possible role of endogenous TRH and an effect of bromocriptine on GH and TSH secretion.
    Demura R; Demura H; Odagiri E; Shizume K
    Endocrinol Jpn; 1984 Dec; 31(6):801-7. PubMed ID: 6442699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete thyrotroph suppression determined by third generation thyrotropin assay in subacute thyroiditis compared to silent thyroiditis or hyperthyroid Graves' disease.
    Ito M; Takamatsu J; Yoshida S; Murakami Y; Sakane S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1997 Feb; 82(2):616-9. PubMed ID: 9024264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly.
    Wüster C; Steger G; Schmelzle A; Gottswinter J; Minne HW; Ziegler R
    Horm Metab Res; 1991 Mar; 23(3):131-4. PubMed ID: 1907592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.